Fuerzas, Aiza Jane M.

HRN: 08-46-90  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2026
METRONIDAZOLE 500MG (TAB)
08/12/2026
08/19/2026
PO
500mg
Q8
Amoebiasis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: